Assertio to Participate in the Maxim Group Healthcare Virtual Summit on October 15, 2024
Rhea-AI Summary
Assertio Holdings, a pharmaceutical company listed on Nasdaq as ASRT, has announced its participation in the Maxim Group 2024 Healthcare Virtual Summit. The company's CEO, Brendan O'Grady, will engage in a fireside chat discussion on October 15, 2024, at 1:00 pm Eastern Time.
The discussion will be hosted by Maxim Group research analyst Naz Rahman. Investors interested in listening to the event can register through the provided link. This participation underscores Assertio's commitment to engaging with the investment community and showcasing its comprehensive commercial capabilities in offering differentiated pharmaceutical products to patients.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, ASRT gained 2.78%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
LAKE FOREST, Ill., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, announced that Brendan O’Grady, Chief Executive Officer, will participate in a fireside chat discussion as part of the Maxim Group 2024 Healthcare Virtual Summit. The fireside chat with Mr. O’Grady, hosted by Maxim Group research analyst Naz Rahman, will occur Tuesday, October 15, 2024 at 1:00 pm Eastern Time.
Investors can register to listen to the event via https://m-vest.com/events/healthcare-10152024.
About Assertio
Assertio is a commercial pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients. We have built our commercial portfolio through acquisition or licensing of approved products. Our commercial capabilities include marketing through both a sales force and a non-personal promotion model, market access through payor contracting, and trade and distribution. To learn more about Assertio, visit www.assertiotx.com.
Investor Contact
Matt Kreps, Managing Director
Darrow Associates
M: 214-597-8200
mkreps@darrowir.com